Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Director departure
|
|
Oak Street Health, Inc. (OSH)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/09/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/04/2023 |
4
| Newlight Partners LP (10% Owner) has filed a Form 4 on Oak Street Health, Inc.|
Txns:
| Disposed/sold 32,550,265 shares
@ $39, valued at
$1269.5M
|
|
| 05/04/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 05/02/2023 |
4
| COOK TIMOTHY M (CFO) has filed a Form 4 on Oak Street Health, Inc.|
Txns:
| Disposed/sold 1,456,206 shares
@ $39, valued at
$56.8M
Disposed/sold 42,241 shares
@ $39, valued at
$1.6M
Disposed/sold 461,510 options to buy
@ $21, valued at
$9.7M
Disposed/sold 10,212 options to buy
@ $21, valued at
$214.5k
Disposed/sold 34,855 options to buy
@ $59.63, valued at
$2.1M
Disposed/sold 281,329 options to buy
@ $15.75, valued at
$4.4M
Granted 73,000 options to buy
@ $21.96, valued at
$1.6M
Disposed/sold 73,000 options to buy
@ $21.96, valued at
$1.6M
|
|
| 05/02/2023 |
4
| Benjamin Regina M. (Director) has filed a Form 4 on Oak Street Health, Inc.|
Txns:
| Disposed/sold 23,881 shares
@ $39, valued at
$931.4k
|
|
| 05/02/2023 |
4
| GUENTHNER ROBERT (Chief Legal Officer) has filed a Form 4 on Oak Street Health, Inc.|
Txns:
| Disposed/sold 489,270 shares
@ $39, valued at
$19.1M
Disposed/sold 220,406 options to buy
@ $21, valued at
$4.6M
Disposed/sold 13,942 options to buy
@ $59.63, valued at
$831.4k
Disposed/sold 134,271 options to buy
@ $15.75, valued at
$2.1M
Granted 49,000 options to buy
@ $21.96, valued at
$1.1M
Disposed/sold 49,000 options to buy
@ $21.96, valued at
$1.1M
|
|
| 05/02/2023 |
4
| PYKOSZ MICHAEL T (CEO) has filed a Form 4 on Oak Street Health, Inc.|
Txns:
| Disposed/sold 6,126,706 shares
@ $39, valued at
$238.9M
Disposed/sold 790,273 shares
@ $39, valued at
$30.8M
Disposed/sold 250,000 shares
@ $39, valued at
$9.8M
Disposed/sold 4,946,638 options to buy
@ $21, valued at
$103.9M
Disposed/sold 168,052 options to buy
@ $21, valued at
$3.5M
Disposed/sold 1,585,677 options to buy
@ $15.75, valued at
$25M
|
|
| 05/02/2023 |
4
| Kusserow Paul B. K. (Director) has filed a Form 4 on Oak Street Health, Inc.|
Txns:
| Disposed/sold 480,013 shares
@ $39, valued at
$18.7M
Disposed/sold 23,342 options to buy
@ $21, valued at
$490.2k
|
|
| 05/02/2023 |
4
| Kaushal Mohit (Director) has filed a Form 4 on Oak Street Health, Inc.|
Txns:
| Disposed/sold 215,224 shares
@ $39, valued at
$8.4M
Disposed/sold 3,501 options to buy
@ $21, valued at
$73.5k
|
|
| 05/02/2023 |
4
| MYERS GRIFFIN (Chief Medical Officer) has filed a Form 4 on Oak Street Health, Inc.|
Txns:
| Gifted 8,500 shares
@ $0
Disposed/sold 8,511 shares
@ $39, valued at
$331.9k
Disposed/sold 4,845,659 shares
@ $39, valued at
$189M
Disposed/sold 1,677,412 options to buy
@ $21, valued at
$35.2M
Disposed/sold 50,890 options to buy
@ $15.75, valued at
$801.5k
|
|
| 05/02/2023 |
4
| Klapstein Julie D (Director) has filed a Form 4 on Oak Street Health, Inc.|
Txns:
| Disposed/sold 31,684 shares
@ $39, valued at
$1.2M
|
|
| 05/02/2023 |
4
| KECK KIM (Director) has filed a Form 4 on Oak Street Health, Inc.|
Txns:
| Disposed/sold 94,960 shares
@ $39, valued at
$3.7M
Disposed/sold 62,374 options to buy
@ $21, valued at
$1.3M
|
|
| 05/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/02/2023 |
4
| CLEM BRIAN (COO) has filed a Form 4 on Oak Street Health, Inc.|
Txns:
| Disposed/sold 569,826 shares
@ $39, valued at
$22.2M
Disposed/sold 198,140 options to buy
@ $21, valued at
$4.2M
Disposed/sold 27,884 options to buy
@ $59.63, valued at
$1.7M
Disposed/sold 281,329 options to buy
@ $15.75, valued at
$4.4M
Granted 73,000 options to buy
@ $21.96, valued at
$1.6M
Disposed/sold 73,000 options to buy
@ $21.96, valued at
$1.6M
|
|
| 05/02/2023 |
4
| PRICE GEOFFREY M (Chief Innovation Officer) has filed a Form 4 on Oak Street Health, Inc.|
Txns:
| Disposed/sold 3,879,525 shares
@ $39, valued at
$151.3M
Disposed/sold 1,080,970 shares
@ $39, valued at
$42.2M
Disposed/sold 1,599,281 options to buy
@ $21, valued at
$33.6M
Disposed/sold 281,329 options to buy
@ $15.75, valued at
$4.4M
Granted 24,000 options to buy
@ $21.96, valued at
$527k
Disposed/sold 24,000 options to buy
@ $21.96, valued at
$527k
|
|
| 05/02/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 05/02/2023 |
POSASR
| Form POSASR - Post-effective Amendment to an automatic shelf registration statement: |
| 05/02/2023 |
8-K
| Resignation/termination of a director|
Docs:
|
"Second Amended and Restated Certificate of Incorporation of Oak Street Health, effective May 2, 2023",
"Second Amended and Restated Bylaws of Oak Street Health, effective May 2, 2023",
"First Supplemental Indenture, to the Indenture, between the Company and U.S. Bank National Association, as trustee",
"CVS Health completes acquisition of Oak Street Health" |
|
| 05/02/2023 |
4
| GENERAL ATLANTIC, L.P. (10% Owner) has filed a Form 4 on Oak Street Health, Inc.|
Txns:
| Disposed of 61,384,475 shares
@ $39, valued at
$2394M
|
|
| 05/02/2023 |
SC 13G/A
| GENERAL ATLANTIC, L.P. reports a 0% stake in Oak Street Health, Inc. |
| 05/02/2023 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 04/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/25/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/25/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/25/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/25/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/25/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/25/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/24/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/20/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 04/20/2023 |
8-K
| Quarterly results |
| 04/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/18/2023 |
144/A
| Form 144/A - Report of proposed sale of securities: [Amend] |
| 04/18/2023 |
144
| Form 144 - Report of proposed sale of securities: |
|
|
|